Catalyst Pharmaceuticals Inc. (CPRX)
NASDAQ · Healthcare
Catalyst Pharmaceuticals Inc. Net Income 2012–2025
Catalyst Pharmaceuticals Inc. annual/quarterly net income history and growth rate from 2012 to 2026. Net income is the total earnings of a company after all expenses, including taxes and interest, have been deducted from total revenues.
- Catalyst Pharmaceuticals Inc. net income for the quarter ending March 31, 2026 was 63.7 M, a 12.33% increase year-over-year.
- Catalyst Pharmaceuticals Inc. net income for the twelve months ending March 31, 2026 was 225.4 M, a 191.96% increase year-over-year.
- Catalyst Pharmaceuticals Inc. annual net income for 2025 was 214.3 M, a 30.78% increase from 2024.
- Catalyst Pharmaceuticals Inc. annual net income for 2024 was 163.9 M, a 129.50% increase from 2023.
- Catalyst Pharmaceuticals Inc. annual net income for 2023 was 71.4 M, a 14.05% decrease from 2022.
- Catalyst Pharmaceuticals Inc. annual net income for 2022 was 83.1 M.
Net Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Catalyst Pharmaceuticals Inc. Net Income — FAQ
Catalyst Pharmaceuticals Inc. (CPRX) net income over the last 14 years — annual and quarterly figures with year-over-year growth and charts.
What is Catalyst Pharmaceuticals Inc.'s net income?
Catalyst Pharmaceuticals Inc. (CPRX) reported net income of $214M for fiscal 2025.
Where can I see CPRX's net income history?
The chart and table above show Catalyst Pharmaceuticals Inc.'s net income by year and by quarter, including the growth rate.